Celltrion Pharm

068760.KQ

38.61 USD

0.18

+0.47%

Overview

Last close

38.61 usd

Market cap

1.68B usd

52 week high

69.97 usd

52 week low

30.18 usd

Target price

95.39 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

8.5509

Price/Book Value

5.6906

Enterprise Value

1.70B usd

EV/Revenue

4.7803

EV/EBITDA

33.5359

Key financials

Revenue TTM

192.70M usd

Gross Profit TTM

56.70M usd

EBITDA TTM

30.02M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

538.06M usd

Net debt

89.30M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.